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Abstract: 
 
The aim was to detect cancer cells by using folate–PEG-Biotin probe with 
fluorescently labeled streptavidin for targeted drug delivery of anti-cancer drugs and 
diagnose cancer cells. Folate-PEG-Biotin (synthesized by Dr. Henne and Mr.Rohan 
Patel) was purified by HighPeformanceLiquidChromatography (HPLC) analysis and with 
the help of Liquid Chromatography/Mass Spectrometry (LC/MS) its identity was 
confirmed. Folate is a basic composition of cell metabolism in both synthesis of DNA 
and proteins. Growing cancer cells require high level of folic acid. Folate Receptor-α 
(FR-α) is a membrane bound protein having high affinity for folic acid and serves to 
transport of folate into cells1. Poly ethylene glycol work as spacer and reduce the steric 
hindrance between peptide and biotin. Biotin is a B-complex vitamin, which is having 
highest non-covalent affinity to streptavidin. Streptavidin biotin conjugate with folate 
helps in identifying and detection of cancer cells. We used fluorescently labeled 
streptavidin and incorporated it with Folate-PEG-Biotin Probe to detect cancer cells2. We 
also studied cell capture by adding fluorescently labeled streptavidin along with 1000-
fold excess of folic acid. This work was collaborated with Dr. Tim Gsell by using his 
high-resolution camera capable of capturing multi-fluorophore fluorescent images. Based 
on this study, further studies may include incorporation of releasable specific Anti-cancer 
drug to folate-PEG probe. 
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Introduction 
 
Folate: 
 
Folate is an essential vitaminneeded for the formation of DNA and Protein 
synthesis in the human body. Folate helps in the formation of healthy red blood cells. 
Folate with the combination of methionin and vitamin-B6 can help to reduce the risk of 
lung cancer by two-thirds. However, Folate deficiency can cause DNA precursor 
imbalance and promotes chromosome breakage, thus increasing the risk of prostate 
cancer development.The effect of folate on cancer is complex, Adequate level of folate 
reduce the risk of esophageal, lung, and ovarian cancer but also assist rapid cell division 
and cell growth of cancer cells even in people who are already suffering from cancer3. 
 
Folate receptor: 
 
Significantdevelopments have been madein Anti-cancer technology, though 
Cancer is not completely curable.Major problems with anti-cancer treatments like 
chemotherapy and hormontherapy is their poor selectivity for cancer cells and severe 
toxicity to normal cells. Folate Receptor (FR-α)can helpto overcome this problem4.  
Folate-Receptors are found at high to moderate levels in a kidney, lung, brain, and 
breast carcinomas. It also found in normal cells but at very low level5. The density of FR-
α increases as the stage of cancer increases6. As such, Folate conjugation to anti-cancer 
drugs will improve drug selectivity and decrease side effects. Folate conjugation allows a 
drug molecule to target and become endocytosed into FR- Positive cancer cells7. 
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Folate-PEG-Biotin: 
 
We have used Folate-PEG- Biotin with fluorescently labeled streptavidin for 
detection and diagnosis ofcancer cells. Folate-PEG-Biotinis inexpensive and can be   
more easily produced than other more costly anti-body based conjugates. Biotin is a B 
complex vitamin, which canbe chemically linked to proteins like streptavidin. Biotin 
shows high affinity and specificity for streptavidin8. Polyethylene Glycol used as a 
spacer, increases conjugate solubility and helps to reduce steric hindrance between the 
cell receptor and streptavidin. Alternative spacer lengths enable optimization of 
conjugate function for specific biotin-binding assays involving streptavidin. We candetect 
cancer cells by binding withfluorescently labeledstreptavidin to folate through biotin and 
observing under fluorescence microscope with a high-resolution camera capable of 
capturing multi-flouorophore images. 
Streptavidin: 
 
Streptavidin is a tetramer protein that has an extremely high affinity for biotin. We have 
used fluorescently labeled streptavidin labeled with Oregon-green dye. The high affinity 
of streptavidin for biotin has made it useful for many bioanalytical applications involving 
the immobilization of proteins, vesicles, and other biomolecules, as well as imaging. 
 
 
 
 
 Take one drop on slide and observe under Microscope.
Again centrifuge the material and wash with PBS.
Incubate For 30 min at 37
Add 10µL (100 nM final Concentration) Oregon Green Streptavidin 
Centrufuge  the Material and wash with PBS
Incubate for 30 min. at 37
Add10µL (100nM final concentration)Folate
8
CellStudy
C.
(3 times)
C
-PEG
Cancer Cell(L1210)100kL
 
-Biotin
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Materials 
RPMI medium 1640  
(GIBCO)  
Lot # 27016 
 [+] L- Glutamine 
[+] Phenol red 
[-] Folic acid. 
 
 
[Thermo-Scientific] 
Product# 22832 
Lot# LA142162 
1ml(1mg/ml)  
 
PBS 1X 
With out calcium and magnesium 
Cat. # 21-040-cv 
Lot # 21040174 
EXP 07/11 
Mediatech, INC Cellgro. 
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Purification and Analysis of Folate-PEG-Biotin 
 
We needed to purify Folate-PEG-Biotin probe (prepared by Dr. Henne and 
Mr.Rohan Patel) by HPLC method using the Hewelett Packard, series-1050 instrument 
that is equipped with a Diode Array Detector. 
Rigel 5µm C-18 10 X 250 nm columns were used for purification purpose and 
Ammonium bicarbonate was used as a buffer. 
Parameters for HPLC: 
Solvent A: Ammonium bicarbonate 
Solvent B: Acetonitrile 
Flow Rate:  1ml/min 
Run Time:  60 min. 
Column: Rigel 5µm C-18 
 
 
No 
Time 
(Min) 
% Solvent  
 
B 
1 
 
0.0 1.0 
2 
 
5.0 1.0 
3 
 
35.0 30 
4 
 
45.0 50 
5 
 
55.0 60 
6 
 
60.0 1.0 
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LC/MS: 
 
Once we had collected the purified Folate-PEG probe by HPLC method, we 
needed to further analyze it with LCMS to confirm the identity and check the purity. 
We have used eclipse XDB C-18 column with 1% Formic acid in Acetonitrile and water 
as mobile phase in positive ion mode and eclipse XDB C-18 column with Methanol and 
water as mobile phase in negative ion mode. 
Parameters For LC/MS: 
Solvent for Positive Ion mode: 1% Formic acid, Acetonitrile, water. 
Solvent for Negative Ion mode: Methanol and water. 
Flow rate:  0.5 ml/min 
Run time:  10 min. 
Scale range:  600-1000 m/z 
Sample size: 30 µl (200 ppm) 
 
 
  
 
 
No. Time in Min % Methanol 
 
1 
 
0 30 
2 
 
1 50 
3 
 
2 70 
4 
 
3 90 
5 
 
4 90 
6 
 
5 90 
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Result and Discussion 
 
We have used HPLC for separation and purification of Folate-PEG-Biotin. By 
using the reverse phase chromatography technique, we got the separation peak for Folate-
PEG-Biotin at around 37 min. The compound, which separated at 37 min, was found to 
be Folate-PEG-Biotin by DAD spectra, which shows absorbance at 284nm and 350nm. 
Small peaks indicate some impurities in the compound. Once we purified the Folate-
PEG-Biotin, it was further analyzed by LC/MS to confirm its identity. In negative ion 
mode we got peak at 868 (m-1). The calculated value for Folate-PEG-Biotin is 869. Some 
fragments occurred at 890 and 891 and may be attributed to the impurities in the solvent. 
We did two different cell studies. One was with Folate-PEG-Biotin and Oregon 
green dye and another with Folate-PEG-Biotin,Oregon green dye, and excess of Folic 
acid. For the first study, we observed fluorescentlylabeled cancer cells under a 
fluorescent microscope and these images were captured with a camera. For the second 
study, the excessof folic acid wastaken by folate receptor, thus preventing the uptake of 
fluorescently labeled streptavidin. Taken, together these results indicate we have selective 
binding of the folate probe to the L-1210 cancer cells.    
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Conclusion: 
 
 
 
 
By using reverse phase chromatography in both HPLC and LC/MS we can, purify 
 and confirm the detection of Folate PEG Biotin respectively. In HPLC, the peak at 37 
min and the DAD spectra at 284nm and 350 nm confirm the identity of Folate PEG 
Biotin. In LC/MS, (negative ion mode) using methanol and water as mobile phase the 
molecular ion peak at 868(M-1) is that of folate-PEG-Biotin which relates to the 
calculated molecular weight of that compound. In cell studies fluorescently labeled 
streptavidin bound to Folate-PEG-Biotin detects and diagnoses cancer cells, however, 
with an 1000 fold excess of folic acid, the excess of folate binds with the folate receptor 
and thus cancer cells are not detected. 
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